Low-income Americans smoke cigarettes at higher rates and quit less than other groups. To increase their engagement in and success using evidence-based cessation methods, we tested two interventions using a 2x2 randomized factorial design: (1) telephone navigation to reduce financial strain and address social needs such as food, rent and utility payment; and (2) a specialized tobacco quitline designed for low-income smokers. From June 2017 to November 2020, we enrolled 1,944 low-income smokers in Missouri, USA, recruited through the Missouri 2-1-1 helpline, into the trial. This paper describes recruitment, key characteristics and life circumstances of this high-risk population. After eligibility screening, 1,944 participants completed baseline and were randomized. Participants were racially diverse (58% African American), poor (51% < $10,000 annual pre-tax household income) and many reported less than high school education (30%). They reported a mean of 2.5 unmet social needs, especially childcare and paying bills, had high rates of stress, depressive symptoms and sleep problems, and most were in fair or poor health. There were few differences between these variables, and no differences between tobacco use and cessation variables, across the four study groups and between participants recruited pre and during the COVID-19 pandemic. Trial recruitment through the 2-1-1 helpline is feasible for reaching a population of low-income smokers. Low-income smokers face myriad daily challenges beyond quitting smoking. Cessation interventions need to account for and address these life circumstances. Clinicaltrials.gov NCT03194958.
8 September 2021 in Contemporary Clinical Trials Communications
Approximately 57,000 dual users of cigarettes and e-cigarettes call state tobacco quitlines in the U.S. each year. This paper describes a behavioral intervention for dual users of cigarettes and e-cigarettes designed to increase cigarette abstinence. It also presents baseline data from a randomized pilot comparing the Enhanced E-cigarette Coaching (EEC) intervention with quitline treatment as usual (TAU). Oklahoma Tobacco Helpline callers were recruited at registration and randomized to EEC (n = 46) or TAU (n = 50). Treatment included 5 coaching calls and free nicotine replacement therapy (NRT). EEC treatment included enhanced e-cigarette assessment, education, a shared decision-making quit plan development approach, and tailored behavioral support. Participants averaged 40.6 years of age and 19.2 cigarettes per day; 85% smoked daily, 48% vaped daily, and 53% reported medium to high e-cigarette dependence. Most reported using e-cigarettes to quit (43%) or to cut down (26%) on smoking. Most had previously tried to quit smoking (91%) and had tried FDA-approved cessation medications (79%). Beliefs about vaping, NRT, and smoking included misinformation. After discussing the relative risks of NRT, vaping, and smoking, most EEC participants (89%) selected a quit plan that incorporated both NRT and vaping. At baseline, most participants reported a history of failed quit attempts with NRT and were vaping to quit or cut down on smoking, but they may need more support to completely quit smoking. If the EEC improves smoking outcomes, it would provide needed guidance on behavioral support best practices for individuals who vape and want to quit smoking.
10 June 2023 in American Journal of Preventive Medicine
Background: Internal medicine physicians are often the first providers to encounter patients with a new diagnosis of tuberculosis. Given the public health risks of missed tuberculosis cases, assessing internal medicine residents’ ability to diagnose tuberculosis is important.Methods: Internal medicine resident knowledge and practice patterns in pulmonary tuberculosis diagnosis at 7 academic hospitals were assessed utilizing (a) a 10-item validated pulmonary tuberculosis diagnosis assessment tool and (b) a retrospective chart review of 343 patients who underwent a pulmonary tuberculosis evaluation while admitted to a resident-staffed internal medicine or infectious disease service. Our primary outcomes were the mean score and percentage of correct responses per assessment tool question, and the percentage of patients who had Centers for Disease Control and Prevention–recommended tuberculosis diagnostic tests obtained.Results: Of the 886 residents who received the assessment, 541 responded, yielding a response rate of 61%. The mean score on the assessment tool (SD) was 4.4 (1.6), and the correct response rate was 57% (311/541) or less on 9 of 10 questions. On chart review, each recommended test was obtained for ≤43% (148/343) of patients, other than chest x-ray (328/343; 96%). A nucleic acid amplification test was obtained for 18% (62/343) of patients, whereas 24% (83/343) had only 1 respiratory sample obtained. Twenty patients were diagnosed with tuberculosis.Conclusions: Significant knowledge and practice gaps exist in internal medicine residents’ abilities to diagnose tuberculosis. As residents represent the future providers who will be evaluating patients with possible tuberculosis, such deficiencies must be addressed.
BACKGROUND State tobacco quitlines provide cessation support and nicotine replacement therapy (NRT) to United States (US) residents. Although live phone coaching is the primary method of providing behavioral support, text messaging programs have been used as supplemental treatment in most US quitlines for more than a decade. Automated short message service (SMS) text messaging programs provide daily educational and motivational text messages. However, these programs cannot provide personalized messaging or respond to participant questions. OBJECTIVE The purpose of this pilot was to test the feasibility of delivering “Hope” a novel AI-based text messaging program to enrollees in a large state quitline. Hope is an AI-native SMS text-based conversational agent designed to provide highly personalized messaging and real-time responses to participant questions. METHODS The pilot study was conducted in November and December of 2025 with quitline enrollees in a large state who were offered Hope (described as an AI-based text messaging program). All those who enrolled in Hope received a 2-month follow-up survey. Primary outcomes were program feasibility and acceptability, measured by program acceptance rates (participants electing to use the Hope program), early opt out rates (participants stopping the program within the first two weeks), incidence of technical problems and engagement. Secondary outcomes included participant satisfaction as well as measures of trust and therapeutic alliance with the conversational agent. Data from a usual care (non-AI) quitline based text program, Text A Coach (TAC), from November and December 2024 was used as a reference. RESULTS Enrollment: 2933 tobacco users enrolled in the HOPE program during the pilot period which was 54% of quitline enrollees during that time (similar to the 52.6% acceptance rate for TAC in 2024). Opt-out rate within the first two weeks was 4.2% for Hope, and 13.3% for TAC (p <.001) and 4% of survey respondents reported technical problems with Hope. More participants engaged with Hope (63.9%) than with TAC (29.2%, p<.001). Hope program users had modest increases in quitline engagement, including higher rates of accepting NRT from the quitline than those in TAC (90.5% vs. 85.5%, ᵡ2=34.47, p<.001). Of the 2933 Hope enrollees, 810 completed the 2-month survey (27.6%). Overall participant satisfaction with Hope was rated as high, as was trust in, and therapeutic alliance with, the conversational agent. CONCLUSIONS Piloting an AI-based tobacco treatment texting program as an adjunct to tobacco quitline services was feasible with few technology difficulties and showed high acceptability. Hope users had higher engagement than the standard text program and modestly higher quitline engagement, including a higher rate of accepting NRT. Together this data suggests that in at least one text messaging application, artificial intelligence appeared to improve upon standard tobacco treatment.